PDCD1 and colonic neoplasm: Of note, the present work amply proved these points: Iacs-miR-30C effectively sensitized both potency of 5-Fu in PDX model of colon cancer (Fig. 5) and Anti-PD1 in B16F10 homograft model of melanoma (Fig. 6).